Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism FtsZ inhibitors(bacterial FtsZ inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H25F3N4O2 |
InChIKeyYZYYZBRKKQNWIR-UHFFFAOYSA-N |
CAS Registry1456882-86-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tuberculosis | Preclinical | US | 15 Apr 2014 |